Sarepta Therapeutics, Inc.
Follow13F filer, CIK 873303, Cambridge, MA
Sarepta Therapeutics, Inc. reported $0 across 1 holding for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-349827
- Period
- 2026-06-30
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 0
- Sold out
- 0
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001193125-26-349827, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | 0 | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-349827 | base | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-349827 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-221713 | Quarter ended 2026-03-31 | 2026-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-049427 | Quarter ended 2025-12-31 | 2026-02-13 | acceptance time not in the bulk data set |